Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

Not yet recruiting

• Conditions: Hiv Infection; Hepatitis B

• Registration Number: NCT06421259
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

In order to assess the risk of hepatitis B reactivation in people living with HIV and undergoing injection therapy, we propose to carry out a descriptive analysis of the evolution of hepatitis B markers in this population.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-03
• Study First Submitted: 2024-05-13
• Study First Submitted QC: 2024-05-15
• Last Update Submitted: 2024-05-15
• Study Start: 2024-05-20
• Study First Posted: 2024-05-20
• Last Update Posted: 2024-05-20
• Primary Completion: 2026-05-20
• Study Completion: 2026-05-20

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

-HIV infected patients under injectable ART

Exclusion Criteria

-Active HBV infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Risk of HBV reactivation under injectable HIV ART	From start of injectable HIV treatment to hepatitis B reactivation, assessed up to 24 months	HBV serology, DNA HBV levels

Trial Locations

Locations (1)

CHU NiICE; 🇫🇷 Nice, Alpes Maritimes, France